(Q41057422)

26 September 2017

1 reference

title

Clarithromycin against Mycobacterium avium complex infections (English)

1 reference

Mycobacterium avium avium

26 September 2017

1 reference

1 reference

Heifets LB

1

1 reference

26 September 2017

publication date

1 February 1996

1 reference

Tubercle and lung disease

26 September 2017

published in

1 reference

26 September 2017

volume

77

1 reference

26 September 2017

issue

1

1 reference

26 September 2017

page(s)

19-26

1 reference

Studies on the epidemiology of nontuberculous mycobacteriosis in Japan

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Epidemiologic Studies of Lung Disease Due to Mycobacteria Other than Mycobacterium tuberculosis in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Isolation of nontuberculous mycobacteria in the United States, 1980

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Disease due to Mycobacterium avium-intracellulare

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Mycobacterium avium complex infection in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Mycobacterium avium and Mycobacterium intracellulare infections in patients with and without AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Geographic distribution, frequency, and specimen source of Mycobacterium avium complex serotypes isolated from patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

CLINICAL ASPECTS, MEDICAL AND SURGICAL, IN THE MANAGEMENT OF BATTEY-TYPE PULMONARY DISEASE.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Treatment of Disease Due to Mycobacterium intracellulare

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Development of effective drug combinations for the inhibition of multiply resistant mycobacteria, especially of the Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Evaluation of new anti-infective drugs for the treatment and prevention of infections caused by the Mycobacterium avium complex. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Choice of antimicrobial agents for M. avium disease based on quantitative tests of drug susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

The Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Drug-food interaction potential of clarithromycin, a new macrolide antimicrobial

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Effectiveness of the macrolide clarithromycin in the treatment of Mycobacterium avium complex infection in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Clinical trials in Mycobacterium avium therapy: lessons to take home.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Mycobacterium avium strains resistant to clarithromycin and azithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

The New Macrolide Antibiotics: Azithromycin, Clarithromycin, Dirithromycin, and Roxithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

In vitro and in vivo activities of clarithromycin against Mycobacterium avium

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

The in-vitro bactericidal activities of combinations of antimicrobial agents against clinical isolates of Mycobacterium avium-intracellulare

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Comparative in-vitro activity of twenty antimicrobial agents against clinical isolates of Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Effect of pH on radiometric MICs of clarithromycin against 18 species of mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Effect of carbon dioxide and pH on susceptibility of Bacteroides fragilis group to erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

An in-vitro evaluation of the cellular uptake and intraphagocytic bioactivity of clarithromycin (A-56268, TE-031), a new macrolide antimicrobial agent

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Penetration of macrolides into human polymorphonuclear leucocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Uptake of clarithromycin by rat lung cells

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Accumulation of clarithromycin in macrophages infected with Mycobacterium avium

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

MICs and MBCs of clarithromycin against Mycobacterium avium within human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Comparison of the intracellular activities of clarithromycin and erythromycin against Mycobacterium avium complex strains in J774 cells and in alveolar macrophages from human immunodeficiency virus type 1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Inhibition of intracellular growth of Mycobacterium avium by one pulsed exposure of infected macrophages to clarithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Activity of clarithromycin against Mycobacterium avium complex infection in beige mice

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Development of streptomycin resistant strains of tubercle bacilli in pulmonary tuberculosis; results of simultaneous sensitivity tests in liquid and on solid media

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Quantitative cultures and drug susceptibility testing of Mycobacterium avium clinical isolates before and during the antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Bacteriostatic and bactericidal activities of gentamicin alone and in combination with clarithromycin against Mycobacterium avium

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige mice

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Amikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige mice

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Activity of rifabutin alone and in combination with clofazimine, kanamycin and ethambutol against Mycobacterium intracellulare infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Continuous high-grade mycobacterium avium-intracellulare bacteremia in patients with the acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990070-2

7 January 2021

10.1016/S0962-8479(96)90070-2

Identifiers

DOI

1 reference

26 September 2017

1 reference